SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-17-000075
Filing Date
2017-08-03
Accepted
2017-08-03 17:04:55
Documents
95
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2017063010qdoc.htm 10-Q 1713633
2 RATIO OF EARNINGS TO FIXED CHARGES pdli-2017063010qex121.htm EX-12.1 59931
3 CERTIFICATION pdli-2017063010qex311.htm EX-31.1 10999
4 CERTIFICATION pdli-2017063010qex312.htm EX-31.2 11262
5 CERTIFICATION pdli-2017063010qex321.htm EX-32.1 14282
12 pdllogoea.jpg GRAPHIC 21306
  Complete submission text file 0000882104-17-000075.txt   10569443

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20170630.xml EX-101.INS 2463847
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20170630.xsd EX-101.SCH 94265
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20170630_cal.xml EX-101.CAL 121444
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20170630_def.xml EX-101.DEF 444065
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20170630_lab.xml EX-101.LAB 837921
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20170630_pre.xml EX-101.PRE 596211
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 171005902
SIC: 2836 Biological Products, (No Diagnostic Substances)